Pure Appl. Chem., 2000, Vol. 72, No. 3, pp. 479-552
doi:10.1351/pac200072030479
INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE
SCIENTIFIC DIVISION
COMMITTEE ON NOMENCLATURE, PROPERTIES, AND UNITS
CHEMISTRY AND HUMAN HEALTH DIVISION
CLINICAL CHEMISTRY SECTION
COMMISSION ON NOMENCLATURE, PROPERTIES, AND UNITS
Properties and units in the clinical laboratory sciences. Part XII. Properties and units in clinical pharmacology and toxicology (Technical Report) (IFCC-IUPAC 1999)
Henrik Olesen*, David Cowan, Rafael De La Torre, Ivan Bruunshuus, Morten Rohde and Desmond Kenny
1Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark; 2Drug Control Centre, London University, King's College, London, UK; 3IMIM, Dr. Aiguader 80, Barcelona, Spain; 4Dept. of Clinical Biochemistry, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland
Abstract:
The term designating a substance being an active ingredient of a drug may be a generic name, a nonproprietary name, a registered trade name, a fantasy name, or other. This causes difficulties in the transmission of requests and reports on properties for such substances in biological fluids to and from the clinical laboratories, and in the collating of this information from different sources.
The document comprises a list of properties of drugs in biological
fluids for use in electronic transmission systems. Systematic names
are presented together with a code value for each.
*Corresponding author.
Please forward comments to: H. Olesen, Office of Laboratory
Informatics 76-6-1, Copenhagen University Hospital (Rigshospitalet),
9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: holesen@rh.dk